Company Filing History:
Years Active: 2016-2018
Title: Innovations by Jean-Claude Amélia in Hadron Therapy
Introduction
Jean-Claude Amélia is a notable inventor based in Erquelinnes, Belgium. He has made significant contributions to the field of hadron therapy, focusing on advancements that enhance treatment delivery and imaging capabilities. With a total of 2 patents, Amélia's work is pivotal in improving cancer treatment methodologies.
Latest Patents
Amélia's latest patents include a "Hadron therapy installation comprising an imaging device" and a "Gantry structure for a hadron therapy apparatus." The first invention relates to a hadron therapy installation that features an irradiation unit supported by a rotary support structure. This design allows the unit to rotate around a target volume, delivering treatment beams from various angles. An imaging device is integrated with the irradiation unit, enabling it to rotate around the target volume, which is essential for methods like cone beam computed tomography and fluoroscopic imaging. The second patent describes a gantry structure designed for pivoting about an axis of rotation, delivering a hadron beam to a target. This structure includes a beam delivery line that is self-supporting and strategically designed to maintain balance through a counterweight system.
Career Highlights
Jean-Claude Amélia is associated with Ion Beam Applications S.A., a company that specializes in the development of advanced medical technologies. His work at this organization has been instrumental in pushing the boundaries of hadron therapy, making it a more effective treatment option for patients.
Collaborations
Amélia collaborates with talented professionals such as Alexandre Debatty and Sébastien De Neuter. Their combined expertise contributes to the innovative projects at Ion Beam Applications S.A.
Conclusion
Jean-Claude Amélia's contributions to hadron therapy through his patents and collaborations highlight his role as a key innovator in the medical technology field. His work continues to influence advancements in cancer treatment, showcasing the importance of innovation in healthcare.